Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Pre Close trading update

24 Jan 2013 07:00

RNS Number : 2468W
Barr(A.G.) PLC
24 January 2013
 



A.G. BARR p.l.c.

 

Pre Close trading update

 

 

A.G. BARR p.l.c., the soft drinks group, today announces that trading in the final quarter of the financial year is expected to have performed ahead of the total soft drinks market.

 

It is anticipated that total sales in the final quarter will be over 5% ahead of the prior year. The performance in the final quarter is particularly pleasing given the double digit year on year growth in the same period last year. This will give a full year revenue expectation of circa £253 million reflecting a year on year growth of circa 7%.

 

Despite very poor summer weather and a competitive market place, all of our core brands grew in the year. IRN-BRU performed well in challenging conditions with a very positive consumer response to the 'IRN-BRU gets you through' marketing campaign. Rubicon and KA have continued to build on strong prior year performances and the Barr brand has maintained its double digit growth performance. Rockstar has seen a step change in its performance, benefiting from a buoyant energy category and strong trading execution across the year.

 

The operational performance of the business has improved across the financial year with excellent customer service across the final quarter.

 

Our investment in the Crossley site at Milton Keynes is progressing well - on time and to budget. It is expected that commercial production will commence in the summer of 2013.

 

Over the period our free cashflow generation and balance sheet have remained strong, with net debt in line with expectations allowing for the impact of the expenditure on the Milton Keynes project and the acceleration of the dividend paid in January 2013.

 

A.G. Barr remains on course to meet its expectations for the financial year ending 26 January 2013.

 

Barr Britvic merger

 

There is no further update following the rescheduled expected OFT decision date of 13 February 2013. As previously announced, the parties continue to work towards the implementation of the merger, with the effective date currently expected to be 26 February 2013.

 

Outlook

 

A.G. Barr has delivered a robust performance in a market place impacted by the combination of very poor summer weather and the ongoing economic challenges faced by consumer goods companies, notably raw material cost pressures and inconsistent consumer demand. Looking forward, it is unlikely that these challenges will materially change, however we remain cautiously optimistic that the combination of our proven operating model, continued focus on efficiency, strong brand equity, sound balance sheet and growth potential leave us well placed to continue to build on this performance.

 

A.G. Barr intends to announce its full year financial results on 21 March 2013.

 

24 January 2013

 

A.G. Barr

Tel: 01236 852400

Roger White, Chief Executive

Alex Short, Finance Director

College Hill

Tel: 020 7457 2020

Justine Warren

Matthew Smallwood

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUUAGUPWGMW
Date   Source Headline
3rd Jun 20267:00 amRNS-RLaunch of IRN-BRU Summer Campaign
27th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSResult of AGM
11th May 20262:46 pmRNSDirector/PDMR Shareholding
21st Apr 202610:43 amRNSAnnual Report and Accounts and Notice of AGM
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
13th Apr 20269:39 amRNSDirector/PDMR Shareholding
7th Apr 202611:21 amRNSDirector/PDMR Shareholding
1st Apr 20268:44 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSFinal Results
23rd Mar 20267:00 amRNS-RLaunch of IRN-BRU 'ZERO'
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSNotice of Results Presentation
9th Feb 20263:56 pmRNSDirector/PDMR Shareholding
4th Feb 20264:16 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSFull Year Trading Update
15th Jan 20267:00 amRNSDirectorate change
12th Jan 202611:00 amRNSDirector/PDMR Shareholding
8th Dec 20252:49 pmRNSDirector/PDMR Shareholding
19th Nov 20251:44 pmRNSHolding(s) in Company
17th Nov 20253:25 pmRNSDirector/PDMR Shareholding
10th Nov 20254:44 pmRNSDirector/PDMR Shareholding
10th Nov 20254:38 pmRNSDirector/PDMR Shareholding
8th Oct 20252:39 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSInterim Results
11th Sep 20252:00 pmRNSNotice of Results
10th Sep 20256:00 pmRNSDirector/PDMR Shareholding
28th Aug 20252:00 pmRNS2025 Annual General Meeting Update
12th Aug 20254:01 pmRNSDirector/PDMR Shareholding
1st Aug 20257:01 amRNSDirector Declaration
29th Jul 20257:00 amRNSTrading Statement
9th Jul 202511:00 amRNSAppointment of Non-Executive Director
8th Jul 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jul 202511:09 amRNSDirector/PDMR Shareholding
11th Jun 202511:01 amRNSDirector/PDMR Shareholding
10th Jun 20254:20 pmRNSDirector/PDMR Shareholding
10th Jun 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSCapital Markets Event
23rd May 20255:36 pmRNSResult of AGM
12th May 20251:54 pmRNSDirector/PDMR Shareholding
30th Apr 20259:15 amRNSPotential disposal of Strathmore Business
28th Apr 20253:16 pmRNSDirector/PDMR Shareholding
28th Apr 20253:15 pmRNSDirector/PDMR Shareholding
22nd Apr 202510:24 amRNSAnnual Financial Report
9th Apr 202511:23 amRNSDirector/PDMR Shareholding
8th Apr 20253:29 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSResults for year ended 25 January 2025
10th Mar 20252:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.